• Partial β-Secretase Inhibition Reduces Amyloid β Without Syn

  2026-06-03

  Satir et al. demonstrate that moderate inhibition of β-secretase can lower amyloid β production by up to 50% without impairing synaptic transmission in cultured neurons. These findings clarify a critical threshold for therapeutic targeting in Alzheimer's disease models, suggesting that incomplete enzyme inhibition may balance efficacy and safety.

• EZ Cap Cy5 Firefly Luciferase mRNA: Applied Workflow & Optim

  2026-06-03

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) from APExBIO revolutionizes mRNA delivery and quantification by enabling dual-mode imaging—fluorescent and bioluminescent—in a single reagent. Its unique combination of Cy5 labeling, 5-moUTP modification, and Cap1 structure delivers highly stable, immune-quiet, and trackable mRNA for advanced translational research.

• Reversine and Aurora Kinase Inhibition: Unraveling Mitotic C

  2026-06-02

  Explore how Reversine, a potent Aurora kinase inhibitor, uniquely enables advanced interrogation of mitotic checkpoint control and cell cycle disruption in cancer research. This in-depth guide provides new scientific context and practical protocols for translational applications.

• Amiloride (MK-870): Advancing Sodium Channel Research Workfl

  2026-06-02

  Amiloride (MK-870) from APExBIO redefines sodium channel and ion transport research with precision ENaC and uPAR inhibition. This article offers actionable workflows, troubleshooting strategies, and context from recent clinical advances, positioning amiloride as an essential tool for translational studies in epithelial physiology.

• Rhodamine B: Bridging Drift Tracing and Translational Innova

  2026-06-01

  This thought-leadership article explores how Rhodamine B (Basic Violet 10) empowers translational researchers to achieve unprecedented precision in both environmental drift studies and advanced fluorescence-based biological assays. We examine mechanistic insights, protocol parameters, and the future landscape, referencing recent UAV pesticide drift research and differentiating this discussion from conventional product overviews.

• Self-Assembling Virus-Mimicking Particles Enable Extrahepati

  2026-06-01

  The reference study introduces a modular, self-assembling enveloped virus-mimicking particle (EVMP) designed to deliver mRNA efficiently to extrahepatic tissues—overcoming the liver-targeting bias of current platforms. Through rational peptide and lipid design, the work demonstrates robust, safe, and programmable mRNA delivery to organs such as the lung, with significant implications for therapeutic mRNA applications beyond hepatic diseases.

• Cy5.5 NHS Ester: Transforming In Vivo Imaging & Neuromodulat

  2026-05-31

  Explore how Cy5.5 NHS ester (non-sulfonated) advances near-infrared fluorescence imaging for translational neuroscience and tumor biology, bridging mechanistic insight with practical strategies for researchers aiming to innovate in non-invasive diagnostics and therapeutics.

• Tropisetron Hydrochloride: Beyond 5-HT3 Antagonism in Neurop

  2026-05-30

  Explore the multifaceted role of Tropisetron Hydrochloride as a 5-HT3 receptor antagonist in advanced neuropharmacology and transporter interaction research. This in-depth analysis reveals new assay strategies and practical insights for neuroscience receptor modulation.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Reporter Workflow M

  2026-05-29

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) uniquely enables simultaneous bioluminescence imaging and direct fluorescent tracking for precision mRNA delivery studies. Robust Cap1 capping and 5-moUTP modification optimize translation efficiency and minimize immune activation, positioning this APExBIO reagent as a gold standard for advanced gene expression workflows.

• PD0325901: MEK Inhibitor Workflows for Precision Cancer Rese

  2026-05-29

  PD0325901 delivers consistent, selective inhibition of MEK for dissecting oncogenic RAS/RAF/MEK/ERK signaling and enabling reproducible tumor suppression in advanced models. This guide details actionable workflows, troubleshooting tactics, and the integration of new mechanistic insights from translation studies to maximize the compound's impact in experimental oncology.

• FITC Goat Anti-Mouse IgG (H+L) Antibody: Technical Guide

  2026-05-28

  The FITC Goat Anti-Mouse IgG (H+L) Antibody enables sensitive, specific detection of mouse immunoglobulins in immunofluorescence and flow cytometry workflows. It is best suited for research applications requiring fluorescence-based identification of mouse IgG, but is not recommended for direct detection of non-mouse or non-IgG targets. Proper storage and handling are critical to maintaining reagent integrity and minimizing signal variability.

• IR-1061: Enabling Precision NIR-II Imaging in Nanocatalytic

  2026-05-28

  Explore how IR-1061, a near infrared fluorescent dye, advances deep tissue imaging in nanocatalytic cancer therapy. This article uniquely analyzes integration with single-atom nanozyme platforms and provides protocol guidance for molecular imaging researchers.

• (-)-Arctigenin: Mechanistic Leverage for NF-κB and MEK1 in T

  2026-05-27

  This thought-leadership article explores how (-)-Arctigenin, a potent MEK1 inhibitor and NF-κB pathway modulator, offers translational researchers a powerful tool for dissecting and intervening in the tumor-promoting mechanisms of the breast cancer microenvironment. We synthesize mechanistic breakthroughs—such as TAM-derived EV-miR-660’s activation of NF-κB—and provide strategic guidance on the deployment of Arctigenin in advanced cancer models. With competitive insights and a forward-looking perspective, this article bridges mechanistic depth with actionable translational strategy, distinctly advancing beyond standard product overviews.

• Cy5 maleimide (non-sulfonated): Protocols and Best Practices

  2026-05-27

  Cy5 maleimide (non-sulfonated) provides selective, site-specific labeling of cysteine residues in proteins and peptides, making it valuable for fluorescence-based detection and imaging. It is not recommended for protocols requiring high aqueous solubility or non-cysteine labeling strategies. Researchers must follow precise handling and solubilization steps to ensure optimal results.

• Macrophage EVs-miR-660 Drives Breast Cancer via KLHL21/NF-κB

  2026-05-26

  This study uncovers how tumor-associated macrophage (TAM) extracellular vesicles deliver miR-660 to breast cancer cells, downregulating KLHL21 and activating NF-κB signaling, thereby promoting metastasis. These mechanistic insights highlight novel intercellular communication routes in the tumor microenvironment, pointing to new intervention strategies.

16338 records 1/1090 page Next 12345 下5页 Last page